{
    "schema_version": "1.0",
    "classification": {
        "name": "Bladder Pathology Unified Classification",
        "version": "1.0",
        "issued": "2025-06-23",
        "purpose": "Provide a single-source, hierarchical classification for all bladder (urothelial and non-urothelial) specimens — from normal / reactive findings through benign lesions and the full malignant spectrum — to support consistent reporting, data capture, and treatment decision-making."
    },
    "decision_tree": [
        {
            "code": "B0",
            "category": "Normal / Reactive",
            "criteria": "No neoplastic process; purely inflammatory or reactive changes (bacterial, radiation, eosinophilic, interstitial cystitis, etc.)",
            "examples": [
                "Acute bacterial cystitis only"
            ]
        },
        {
            "code": "B1",
            "category": "Benign urothelial lesion",
            "criteria": "Urothelial papilloma, inverted papilloma, cystitis cystica / glandularis",
            "examples": [
                "1 cm inverted papilloma excised"
            ]
        },
        {
            "code": "B2",
            "category": "Atypical / Indeterminate",
            "criteria": "Urothelial proliferation of uncertain malignant potential (UPUMP) / atypical urothelial proliferation (AUP)",
            "examples": [
                "Flat urothelial hyperplasia with atypia insufficient for malignancy"
            ]
        },
        {
            "code": "U1",
            "category": "Low-risk NMIBC",
            "criteria": "PUN-LMP or solitary low-grade Ta",
            "examples": [
                "Single 0.8 cm low-grade Ta"
            ]
        },
        {
            "code": "U2",
            "category": "Intermediate-risk NMIBC",
            "criteria": "Low-grade Ta > 3 cm, multifocal, recurs ≤ 12 mo, or low-grade T1",
            "examples": [
                "Three 4 cm low-grade Ta tumours recurring at 8 mo"
            ]
        },
        {
            "code": "U3",
            "category": "High-risk NMIBC",
            "criteria": "High-grade Ta (any size), high-grade T1, or carcinoma in situ (Tis)",
            "examples": [
                "2 cm high-grade T1 invading lamina propria"
            ]
        },
        {
            "code": "U3+",
            "category": "Very-high-risk NMIBC",
            "criteria": "U3 plus ≥ 1 modifier: BCG-unresponsive, aggressive variant (micropapillary, plasmacytoid, nested, sarcomatoid, small-cell / neuroendocrine), lymphovascular invasion, or prostatic-urethral involvement",
            "examples": [
                "Persistent high-grade T1 after adequate BCG"
            ]
        },
        {
            "code": "U4",
            "category": "Localised muscle-invasive",
            "criteria": "T2 – T4a, N0, M0",
            "examples": [
                "Inner-muscle (T2a) invasion; nodes negative"
            ]
        },
        {
            "code": "U5",
            "category": "Node-positive (non-metastatic)",
            "criteria": "Any T, N1 – N3, M0",
            "examples": [
                "Two obturator nodes (N2) with T3b primary"
            ]
        },
        {
            "code": "U6",
            "category": "Metastatic M1a",
            "criteria": "Any T / N, non-regional lymph-node metastasis only",
            "examples": [
                "Para-aortic nodal spread; no visceral disease"
            ]
        },
        {
            "code": "U7",
            "category": "Metastatic M1b",
            "criteria": "Any T / N, visceral or bone metastasis",
            "examples": [
                "Pulmonary nodules and hepatic lesion"
            ]
        },
        {
            "code": "U8",
            "category": "Non-urothelial primary (high-grade by definition)",
            "criteria": "Pure squamous cell carcinoma, adenocarcinoma, urachal carcinoma, neuroendocrine carcinoma, or other non-urothelial histology",
            "examples": [
                "Muscle-invasive squamous cell carcinoma"
            ]
        }
    ],
    "t_category_reference": [
        "Ta",
        "Tis",
        "T1",
        "T2a",
        "T2b",
        "T3a",
        "T3b",
        "T4a",
        "T4b"
    ],
    "modifiers_glossary": [
        {
            "name": "BCG-unresponsive",
            "definition": "Persistent or recurrent CIS, Ta, or T1 high-grade disease within 6 months of completing adequate BCG (≥ 5/6 induction and ≥ 2/3 maintenance instillations) — or T1/HG recurrence at first evaluation post-induction — per NCCN v1.2025 and EAU 2025 guidance."
        },
        {
            "name": "Aggressive variants",
            "definition": "Micropapillary, plasmacytoid, nested, sarcomatoid, small-cell / neuroendocrine, giant-cell, lymphoma-like, lipid-rich."
        },
        {
            "name": "Lymphovascular invasion (LVI)",
            "definition": "Tumour cells within vascular or lymphatic channels."
        },
        {
            "name": "Prostatic-urethral involvement",
            "definition": "CIS or invasive carcinoma extending into prostatic urethral mucosa or ducts."
        }
    ],
    "narrative_mapping": [
        {
            "narrative": "Low-grade papillary urothelial carcinoma, no lamina propria invasion",
            "interpreted_data": "Ta, low grade; N0 M0",
            "assigned_code": "U1"
        },
        {
            "narrative": "Multiple low-grade Ta tumours up to 4 cm",
            "interpreted_data": "Ta, low grade, > 3 cm & multifocal",
            "assigned_code": "U2"
        },
        {
            "narrative": "High-grade papillary urothelial carcinoma invades lamina propria",
            "interpreted_data": "T1, high grade",
            "assigned_code": "U3"
        },
        {
            "narrative": "High-grade papillary urothelial carcinoma, no LP invasion, CIS present",
            "interpreted_data": "Ta, high grade + concomitant Tis",
            "assigned_code": "U3"
        },
        {
            "narrative": "Persistent high-grade T1 after adequate BCG",
            "interpreted_data": "High-grade T1, BCG-unresponsive",
            "assigned_code": "U3+"
        },
        {
            "narrative": "Urothelial carcinoma invading muscularis propria",
            "interpreted_data": "≥ T2 (muscle invasion)",
            "assigned_code": "U4"
        },
        {
            "narrative": "Urothelial carcinoma with two obturator lymph-node metastases",
            "interpreted_data": "Any T, N2, M0",
            "assigned_code": "U5"
        },
        {
            "narrative": "Metastatic urothelial carcinoma, para-aortic nodal disease",
            "interpreted_data": "M1a (non-regional nodes)",
            "assigned_code": "U6"
        },
        {
            "narrative": "Metastatic urothelial carcinoma, pulmonary nodules",
            "interpreted_data": "M1b (visceral)",
            "assigned_code": "U7"
        },
        {
            "narrative": "Primary squamous cell carcinoma of bladder",
            "interpreted_data": "Non-urothelial histology",
            "assigned_code": "U8"
        }
    ],
    "reporting_template": {
        "pattern": "<Code> (<T N M>, Grade <low/high>, Size cm, Multifocal <yes/no>, Variant <type>, Modifiers <list>)",
        "example": "U3+ (T1 HG N0 M0, size 2 cm, LVI+, BCG-unresponsive)"
    },
    "references": [
        "AJCC Cancer Staging Manual, 8th ed.",
        "NCCN Guidelines® Bladder Cancer v1.2025",
        "WHO Classification of Tumours, Urinary System & Male Genital Organs, 5th ed.",
        "EAU Guidelines on Non-muscle-invasive and Muscle-invasive Bladder Cancer (2025)"
    ],
    "metadata": {
        "document_owner": "Pathology Standards Committee",
        "next_review_due": "2027-06"
    }
}